Company GemPharmatech Co., Ltd.

Equities

688046

CNE100005964

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for GemPharmatech Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 26/06/2024 am IST			5-day change	1st Jan Change
10.94 ^CNY	+1.77%		-0.91%	-45.71%

26/04	GemPharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03/04	Tranche Update on GemPharmatech Co., Ltd.'s Equity Buyback Plan announced on December 27, 2023.	CI

GemPharmatech Co Ltd, formerly Jiangsu Jicui Yaokang Biotechnology Co Ltd, is a China-based company principally engaged in the research, development, production and sales of experimental mouse models. The Company uses gene-editing and other technologies to produce mouse models. The Company also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Companyâs products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.

Number of employees: 1,506

CNY in Million	2022	Weight	2023	Weight	Delta
Commercial Mouse Model 59.0 %	323	62.6 %	367	59.0 %	+13.62%
Functional Efficacy 21.2 %	97	18.8 %	132	21.2 %	+36.09%
Custom Breeding 12.7 %	65	12.5 %	79	12.7 %	+22.24%
Model Creation 5.6 %	23	4.5 %	35	5.6 %	+49.42%
Import and Export Agent and Others 1.4 %	8	1.5 %	9	1.4 %	+15.15%
Other Business 0.1 %	1	0.2 %	0	0.1 %	-48.02%

CNY in Million	2022	Weight	2023	Weight	Delta
China 85.0 %	449	87.1 %	529	85.0 %	+17.70%
Overseas 15.0 %	66	12.9 %	93	15.0 %	+39.94%

Managers	Title	Age	Since
Jing Zhao CEO	Chief Executive Officer	43	01/18/01
Chong Bo Xu DFI	Director of Finance/CFO	41	01/22/01
Cun Xiang Ju CHM	Chairman	40	01/18/01
Tao Wang BRD	Director/Board Member	39	18/23/18
Hui Xin Yang BRD	Director/Board Member	43	01/11/01
Zhong Yu Li BRD	Director/Board Member	60	01/17/01
Yiou Wang SEC	Corporate Secretary	40	01/23/01

Members of the board	Title	Age	Since
De Rong Leng BRD	Director/Board Member	61	19/23/19
Min Min Yang BRD	Director/Board Member	52	19/23/19
Bin Qing Xiao BRD	Director/Board Member	45	01/20/01
Xiang Gao FOU	Founder	61	29/17/29
Jing Zhao CEO	Chief Executive Officer	43	01/18/01
Zhong Yu Li BRD	Director/Board Member	60	01/17/01
Juan Du BRD	Director/Board Member	42	01/20/01
Bo Yu BRD	Director/Board Member	54	01/20/01
Cun Xiang Ju CHM	Chairman	40	01/18/01
Tao Wen BRD	Director/Board Member	45	01/20/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	410,000,000	128,269,365 ( 31.29 %)	0	31.29 %

Name	Equities	%	Valuation
Sinopharm Junbai Tianjin Equity Investment Management Co. Ltd. 17.92 %	26,586,678	17.92 %	43 M ¥
CDH Investments Management (Hong Kong) Ltd. 11.07 %	16,420,533	11.07 %	26 M ¥
Nanjing Biomedical Valley Construction & Development Co. Ltd. 10.81 %	16,038,621	10.81 %	26 M ¥
Jiangsu Industrial Technology Research Institute Co. Ltd. 9.460 %	14,038,621	9.460 %	23 M ¥
Zhong Ou Asset Management Co., Ltd 7.922 %	11,756,580	7.922 %	19 M ¥
Zhoushan Conglomerate Ent Management Pp LP 6.616 %	9,818,182	6.616 %	16 M ¥
GF Fund Management Co., Ltd. 1.185 %	1,759,148	1.185 %	3 M ¥
Fullgoal Fund Management Co., Ltd. 0.7309 %	1,084,655	0.7309 %	2 M ¥
Lion Fund Management Co., Ltd. 0.7286 %	1,081,187	0.7286 %	2 M ¥
Great Wall Fund Management Co., Ltd. 0.6361 %	943,981	0.6361 %	2 M ¥

Name	Equities	%	Valuation
Xiang Gao 77.15 %	201,817,185	77.15 %	325 M ¥
Hai Yan Zhang 4.796 %	12,547,185	4.796 %	20 M ¥
Nanjing Jiangbei New District Management Committee 4.654 %	12,174,545	4.654 %	20 M ¥
Shanghai Yunfeng New Venture Management Co. Ltd. 3.198 %	8,364,809	3.198 %	13 M ¥
Morgan Stanley China Equity Investment Management Co. Ltd. 1.998 %	5,228,013	1.998 %	8 M ¥

GemPharmatech Co., Ltd.

12 Xuefu Road Jiangbei New District

210032, Nanjing

http://www.gempharmatech.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.94 CNY

Average target price

18.71 CNY

Spread / Average Target

+71.02%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
GEMPHARMATECH CO., LTD.	-45.71%	62Cr
MODERNA, INC.	+23.13%	4.69TCr
LONZA GROUP AG	+37.38%	3.91TCr
IQVIA HOLDINGS INC.	-8.73%	3.85TCr
ALNYLAM PHARMACEUTICALS, INC.	+28.09%	3.1TCr
CELLTRION, INC.	-12.26%	2.61TCr
ICON PUBLIC LIMITED COMPANY	+10.57%	2.59TCr
UNITED THERAPEUTICS CORPORATION	+45.05%	1.42TCr
MEDPACE HOLDINGS, INC.	+32.23%	1.25TCr
BIO-TECHNE CORPORATION	-6.56%	1.14TCr

Other Biotechnology & Medical Research